Cargando…

Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction

BACKGROUND: The identification of known mutations in a cell population is important for clinical applications and basic cancer research. In this work an immobilized form of the polymerase chain reaction, referred to as polony technology, was used to detect mutations as well as gene deletions, result...

Descripción completa

Detalles Bibliográficos
Autores principales: Butz, James, Wickstrom, Eric, Edwards, Jeremy
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC183853/
https://www.ncbi.nlm.nih.gov/pubmed/12877750
http://dx.doi.org/10.1186/1472-6750-3-11
_version_ 1782120883293257728
author Butz, James
Wickstrom, Eric
Edwards, Jeremy
author_facet Butz, James
Wickstrom, Eric
Edwards, Jeremy
author_sort Butz, James
collection PubMed
description BACKGROUND: The identification of known mutations in a cell population is important for clinical applications and basic cancer research. In this work an immobilized form of the polymerase chain reaction, referred to as polony technology, was used to detect mutations as well as gene deletions, resulting in loss of heterozygosity (LOH), in cancer cell lines. Specifically, the mutational hotspots in p53, namely codons 175, 245, 248, 249, 273, and 282, and K-ras2, codons 12, 13 and 61, were genotyped in the pancreatic cell line, Panc-1. In addition LOH analysis was also performed for these same two genes in Panc-1 by quantifying the relative gene copy number of p53 and K-ras2. RESULTS: Using polony technology, Panc-1 was determined to possess only one copy of p53, which possessed a mutation in codon 273, and two copies of K-ras2, one wildtype and one with a mutation in codon 12. To further demonstrate the general approach of this method, polonies were also used to detect K-ras2 mutations in the pancreatic cell lines, AsPc-1 and CAPAN-1. CONCLUSIONS: In conclusion, we have developed an assay that can detect mutations in hotspots of p53 and K-ras2 as well as diagnose LOH in these same genes.
format Text
id pubmed-183853
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1838532003-08-27 Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction Butz, James Wickstrom, Eric Edwards, Jeremy BMC Biotechnol Methodology Article BACKGROUND: The identification of known mutations in a cell population is important for clinical applications and basic cancer research. In this work an immobilized form of the polymerase chain reaction, referred to as polony technology, was used to detect mutations as well as gene deletions, resulting in loss of heterozygosity (LOH), in cancer cell lines. Specifically, the mutational hotspots in p53, namely codons 175, 245, 248, 249, 273, and 282, and K-ras2, codons 12, 13 and 61, were genotyped in the pancreatic cell line, Panc-1. In addition LOH analysis was also performed for these same two genes in Panc-1 by quantifying the relative gene copy number of p53 and K-ras2. RESULTS: Using polony technology, Panc-1 was determined to possess only one copy of p53, which possessed a mutation in codon 273, and two copies of K-ras2, one wildtype and one with a mutation in codon 12. To further demonstrate the general approach of this method, polonies were also used to detect K-ras2 mutations in the pancreatic cell lines, AsPc-1 and CAPAN-1. CONCLUSIONS: In conclusion, we have developed an assay that can detect mutations in hotspots of p53 and K-ras2 as well as diagnose LOH in these same genes. BioMed Central 2003-07-23 /pmc/articles/PMC183853/ /pubmed/12877750 http://dx.doi.org/10.1186/1472-6750-3-11 Text en Copyright © 2003 Butz et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Methodology Article
Butz, James
Wickstrom, Eric
Edwards, Jeremy
Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction
title Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction
title_full Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction
title_fullStr Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction
title_full_unstemmed Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction
title_short Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction
title_sort characterization of mutations and loss of heterozygosity of p53 and k-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC183853/
https://www.ncbi.nlm.nih.gov/pubmed/12877750
http://dx.doi.org/10.1186/1472-6750-3-11
work_keys_str_mv AT butzjames characterizationofmutationsandlossofheterozygosityofp53andkras2inpancreaticcancercelllinesbyimmobilizedpolymerasechainreaction
AT wickstromeric characterizationofmutationsandlossofheterozygosityofp53andkras2inpancreaticcancercelllinesbyimmobilizedpolymerasechainreaction
AT edwardsjeremy characterizationofmutationsandlossofheterozygosityofp53andkras2inpancreaticcancercelllinesbyimmobilizedpolymerasechainreaction